SEC Tracker
Get the app

Actuate Therapeutics ACTU

Actuate Therapeutics registers 50,000,000 shares for sale

Securities offering

Form
S-1
Filed
Importance
Notable
  1. 50,000,000 shares of common stock offered
  2. Public offering price assumed at $0.819 per share
  3. Underwriter has 45-day option to purchase additional 7,500,000 shares
  4. Company plans to use proceeds for working capital

Written from the S-1 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Actuate Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Lite Strategy LITS public float $43M, Dec 31, 2025
  2. Actinium Pharmaceuticals ATNM public float $44M, Jun 30, 2025
  3. Fortress Biotech FBIO public float $44M, Jun 30, 2025
  4. CervoMed CRVO public float $40M, Jun 30, 2025
  5. Acumen Pharmaceuticals ABOS public float $45M, Jun 30, 2025